Neil Stuart Horowitz MD
Gynecologic Oncology
Assistant Professor of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital
Join to View Full Profile
75 Francis StBrigham And Women's HospitalBoston, MA 02115
Phone+1 617-732-8843
Fax+1 617-738-5124
Dr. Horowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonResidency, Obstetrics and Gynecology, 1996 - 2000
Duke University School of MedicineClass of 1996
Certifications & Licensure
MA State Medical License 2003 - 2025
MO State Medical License 2000 - 2004
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma Start of enrollment: 2006 Sep 01
- Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar Start of enrollment: 2006 Dec 01
- Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia Start of enrollment: 2012 Jun 18
- Join now to see all
Publications & Presentations
PubMed
- A phase I clinical trial of radiation therapy, durvalumab and tremelimumab in recurrent gynecologic cancer.Kelly J Fitzgerald, Panagiotis Konstantinopoulos, Ursula Matulonis, Joyce Liu, Neil Horowitz
Gynecologic Oncology. 2025-04-23 - Trends in sentinel lymph node evaluation for vulvar melanoma in the United States from 2012 to 2018.Stephanie Alimena, Hadley Reid, Alexandra Bercow, Colleen Feltmate, Jessica St Laurent
Gynecologic Oncology. 2025-04-15 - Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer.Panagiotis A Konstantinopoulos, Mingyang Cai, Elizabeth K Lee, Carolyn Krasner, Susana M Campos
JCO Precision Oncology. 2025-04-01
Journal Articles
- Distinct microRNA Profiles for Complete Hydatidiform Moles at Risk for Malignant ProgressionNeil S Horowitz, Donald P Goldstein, Bradley J Quade, Ross S Berkowitz, Kevin M Elias, American Journal of Obstetrics and Gynecology
Press Mentions
Gemcitabine plus Cisplatin and IMRT Produces Complete Responses in Vulvar CancerMarch 27th, 2023- CRT Regimen Boosts Complete Response Rate in Unresectable Vulvar CancerMarch 27th, 2023
- More Than 110 Dana-Farber Affiliated Faculty Named as 2021 Top Doctors in Boston MagazineJanuary 5th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
